Camgenium’s Medical Device is Supporting Pregnant Women at Risk of Pre-Eclampsia

– Reassure Pregnancy is being used to monitor signs of pre-eclampsia in two NHS hospitals – 

–  Camgenium is pioneering the development of software to ensure high-quality antenatal care is accessible to all women – 

Thursday 26th June 2025, Cambridge, UK – Camgenium, a leading medical device software company, has announced that its software product, ‘Reassure Pregnancy’, can improve outcomes for pregnant women at risk of pre-eclampsia through at-home monitoring. The Reassure Pregnancy system allows women to proactively monitor their symptoms at home using a simple app. Data is shared in real time with clinicians via a dashboard, enabling remote monitoring of women who are at risk of pre-eclampsia.  

 Reassure Pregnancy is currently in use at Milton Keynes University Hospital NHS Foundation Trust and University Hospitals Dorset in Poole. It was first introduced to Milton Keynes University Hospital in November 2018 and later to University Hospitals Dorset in April 2019. Reassure Pregnancy was provided free of charge to both hospitals throughout the COVID-19 pandemic to ensure that individuals in high-risk pregnancies didn’t need to make any unnecessary trips to the hospital, which could have exposed them to the virus. 

 Pre-eclampsia is a medical condition characterised by high blood pressure and the presence of protein in urine.i The preliminary symptoms of pre-eclampsia are often undetected by pregnant women but early diagnosis and management are essential for preventing maternal and neonatal complications.ii Typically, the condition is diagnosed and monitored during routine prenatal appointments at the maternity clinic by measuring blood pressure and urine protein levels.i Women found to be at high risk require more frequent testing which can be burdensome for the mother and is expensive for the clinic. The Reassure Pregnancy app enables frequent testing, saving time and cost for the clinic and, more importantly, ensuring that clinicians can take action at the first sign of a problem. 

 The Reassure Pregnancy app has been developed to empower women to take control of their health throughout pregnancy. Pregnant women can record symptoms and readings of pre-eclampsia from home. Once the symptoms are recorded in the app, the test results are sent in real-time to the clinicians in charge of their care. If any of the symptoms recorded indicate a serious risk to the pregnant woman or unborn child, the system will alert their clinicians immediately. “Our focus is to use technology to improve patient outcomes and enhance efficiencies in patient care,” stated Dr Philip Gaffney OBE, CEO of Camgenium. “The Reassure Pregnancy app enables pregnant women to take control of their health and the health of their unborn child to proactively monitor symptoms which could lead to pre-eclampsia.” 

By enabling the remote monitoring of key pre-eclampsia indicators, Reassure Pregnancy frees up critical clinical time, often saving hundreds of pounds per pregnancy for hospitals. This is especially important for NHS hospitals already under significant pressure. Alerts can be raised within the app and clinician dashboard 24/7, ensuring an efficient process of managing high risk pregnancies for the individual and clinician in charge of their care. Reassure Pregnancy has been designed so that it is easy to add more hospitals to the system, and so that hospitals can only see data for their own patients, ensuring patient data privacy. 

 Despite the immense advances in medical technology, women face many unmet needs within healthcare and there is a clear gap in technology to support women during pregnancy, particularly for women who are at risk of complications.ii Therefore, ensuring that the app was inclusive and accessible to all women was a priority in its development. “When we developed the Reassure Pregnancy app and website, we needed to ensure that pregnant individuals from all backgrounds could use the app with no or minimal training,” said James Belcher, COO at Camgenium. “We also ensured that the app was available in multiple languages so the user could select their preferred language. Inclusivity was an important design criterion for the Reassure Pregnancy app.” 

 The app and the clinical website meet UKCA requirements for medical devices and has been built on Camgenium’s flexible, no code, Xenplate software platform. Camgenium is certified to ISO 13485 and is approved by the NHS to host websites on HSCN, the NHS private network, meaning that patient confidentiality is maintained and secure. Camgenium has NHS-approved IT systems for linking applications on the internet to systems hosted on HSCN. 

Reassure Pregnancy offers a potential lifeline throughout pregnancy that has not previously existed. The successful and prolonged use of this medical device in maternity clinics at Milton Keynes University Hospital NHS Foundation Trust and University Hospitals Dorset in Poole demonstrates the potential of this technology in improving health outcomes for pregnant women and their unborn children. Camgenium has donated blood pressure monitors to both Milton Keynes University Hospital NHS Foundation Trust and University Hospitals Dorset in Poole to ensure Reassure Pregnancy can be available to more women. Camgenium will introduce Reassure Pregnancy to further NHS hospital trusts in the coming months. 

References: [i] Pre-eclampsia. NHS UK. Available at: https://www.nhs.uk/conditions/pre-eclampsia/ Last accessed: May 2025[ii] Warty RR, Smith V, Patabendige M, Fox D, Mol B. Clarifying the unmet clinical need during medical device innovation in women's health - A narrative review. Health Care Women Int. 2024;45(7):811-839. doi:10.1080/07399332.2023.2190983